The MOM permeability is known as a key step in apoptotic signaling, which is regulated by the Bcl-2 family of proteins, and targeting BCL in nonsmall cell lung cancer treatment leads to an initial improvement in chemoresistance (57). This evidence concerns the gene BCL2 and lung cancer.